Forbes -
26 Mar 2014 19:42
Despite continued headwinds from slower generic introduction and severe weather conditions, Walgreen reported a 5.1% year-over-year growth in its Q2 2014 earnings, primarily driven by a 4.3% increase in comparable store sales. Its comparable prescription sales and comparable front-end sales grew by 5.8% and 2% year over year, respectively.
Share this Article
Comment on this Article
Please to comment